Kursprognose für Valion Bio Inc (VBIO)VBIOValion Bio Inc

Alphio's VBIO stock price prediction model matches the current Valion Bio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.83 (-0.67%). The 1-week path is $0.86 (+2.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Tivic Health Systems, Inc. (VBIO) is not a good buy right now due to its extremely low current price of $0.94, a staggering year-to-date change of -97.31%, and an RSI of 9.661 indicating it is heavily oversold. The company is facing significant financial challenges, as evidenced by a net loss of $6.4 million in Q2 2026 and a gross margin of -99.32% in Q3 2025, which raises concerns about its viability. The main risk is the company's high operating expenses and declining cash reserves, with cash and equivalents dropping to $7.2 million from $12.6 million, suggesting liquidity issues.

Valion Bio Inc (VBIO) last closed at $0.84, losing -10.64%. These facts feed the 1-day and 1-week VBIO price prediction above.